Hoch Lynelle has filed 48 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 9796 shares of BRISTOL MYERS SQUIBB CO ($BMY) on March 10, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | A | Performance Shares | 9796 | $0.00 | 9,796.0000 | 2,039,000,000 | 9999.99% | 0.00% |
| March 10, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | A | Market Share Units | 6531 | $0.00 | 6,531.0000 | 2,039,000,000 | 9999.99% | 0.00% |
| March 10, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Performance Shares | 6304 | $0.00 | 0.0000 | 2,039,000,000 | 100.00% | 0.00% |
| March 10, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Market Share Units | 1050 | $0.00 | 1,052.0000 | 2,039,000,000 | 49.95% | 0.00% |
| March 10, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Market Share Units | 838 | $0.00 | 0.0000 | 2,039,000,000 | 100.00% | 0.00% |
| March 10, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | F | Common Stock, $0.10 par value | 912 | $60.13 | 8,210.0000 | 2,039,000,000 | 10.00% | 0.00% |
| March 10, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | J | Common Stock, $0.10 par value | 3095 | $0.00 | 9,122.0000 | 2,039,000,000 | 25.33% | 0.00% |
| March 10, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Common Stock, $0.10 par value | 6304 | $0.00 | 12,217.0000 | 2,039,000,000 | 106.61% | 0.00% |
| March 10, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | F | Common Stock, $0.10 par value | 267 | $60.13 | 5,913.0000 | 2,039,000,000 | 4.32% | 0.00% |
| March 10, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | J | Common Stock, $0.10 par value | 113 | $0.00 | 6,180.0000 | 2,039,000,000 | 1.80% | 0.00% |
| March 10, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Common Stock, $0.10 par value | 1050 | $0.00 | 6,293.0000 | 2,039,000,000 | 20.03% | 0.00% |
| March 10, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | F | Common Stock, $0.10 par value | 212 | $60.13 | 5,243.0000 | 2,039,000,000 | 3.89% | 0.00% |
| March 10, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | J | Common Stock, $0.10 par value | 94 | $0.00 | 5,455.0000 | 2,039,000,000 | 1.69% | 0.00% |
| March 10, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Common Stock, $0.10 par value | 838 | $0.00 | 5,549.0000 | 2,039,000,000 | 17.79% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Market Share Units | 1050 | $0.00 | 2,102.0000 | 2,027,000,000 | 33.31% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | A | Market Share Units | 5021 | $0.00 | 5,021.0000 | 2,027,000,000 | 9999.99% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Performance Shares | 5015 | $0.00 | 0.0000 | 2,027,000,000 | 100.00% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | A | Performance Shares | 7531 | $0.00 | 7,531.0000 | 2,027,000,000 | 9999.99% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Market Share Units | 546 | $0.00 | 0.0000 | 2,027,000,000 | 100.00% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | J | Common Stock, $0.10 par value | 38 | $0.00 | 2,234.0000 | 2,027,000,000 | 1.67% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | F | Common Stock, $0.10 par value | 219 | $63.11 | 2,015.0000 | 2,027,000,000 | 9.80% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Common Stock, $0.10 par value | 835 | $0.00 | 2,850.0000 | 2,027,000,000 | 41.44% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | J | Common Stock, $0.10 par value | 146 | $0.00 | 2,704.0000 | 2,027,000,000 | 5.12% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | F | Common Stock, $0.10 par value | 296 | $63.11 | 2,408.0000 | 2,027,000,000 | 10.95% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Common Stock, $0.10 par value | 1050 | $0.00 | 3,458.0000 | 2,027,000,000 | 43.60% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | J | Common Stock, $0.10 par value | 179 | $0.00 | 3,279.0000 | 2,027,000,000 | 5.18% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | F | Common Stock, $0.10 par value | 374 | $63.11 | 2,905.0000 | 2,027,000,000 | 11.41% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Common Stock, $0.10 par value | 5015 | $0.00 | 7,920.0000 | 2,027,000,000 | 172.63% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | J | Common Stock, $0.10 par value | 1850 | $0.00 | 6,070.0000 | 2,027,000,000 | 23.36% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | F | Common Stock, $0.10 par value | 1359 | $63.11 | 4,711.0000 | 2,027,000,000 | 22.39% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Common Stock, $0.10 par value | 546 | $0.00 | 2,272.0000 | 2,027,000,000 | 31.63% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Market Share Units | 835 | $0.00 | 838.0000 | 2,027,000,000 | 49.91% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Performance Shares | 3268 | $0.00 | 0.0000 | 2,078,000,000 | 100.00% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | A | Performance Shares | 7546 | $0.00 | 7,546.0000 | 2,078,000,000 | 9999.99% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | A | Market Share Units | 5031 | $0.00 | 5,031.0000 | 2,078,000,000 | 9999.99% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | J | Market Share Units | 1050 | $0.00 | 3,152.0000 | 2,078,000,000 | 24.99% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | J | Market Share Units | 835 | $0.00 | 1,673.0000 | 2,078,000,000 | 33.29% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Market Share Units | 544 | $0.00 | 546.0000 | 2,078,000,000 | 49.91% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Market Share Units | 539 | $0.00 | 0.0000 | 2,078,000,000 | 100.00% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | F | Common Stock, $0.10 par value | 917 | $53.79 | 1,726.0000 | 2,078,000,000 | 34.70% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | J | Common Stock, $0.10 par value | 1138 | $0.00 | 2,643.0000 | 2,078,000,000 | 30.10% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Common Stock, $0.10 par value | 3268 | $0.00 | 3,781.0000 | 2,078,000,000 | 637.04% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | F | Common Stock, $0.10 par value | 194 | $53.79 | 513.0000 | 2,078,000,000 | 27.44% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | J | Common Stock, $0.10 par value | 94 | $0.00 | 707.0000 | 2,078,000,000 | 11.74% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Common Stock, $0.10 par value | 544 | $0.00 | 801.0000 | 2,078,000,000 | 211.67% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | F | Common Stock, $0.10 par value | 197 | $53.79 | 257.0000 | 2,078,000,000 | 43.39% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | J | Common Stock, $0.10 par value | 85 | $0.00 | 454.0000 | 2,078,000,000 | 15.77% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hoch Lynelle | President, Cell Therapy Org. | M | Common Stock, $0.10 par value | 539 | $0.00 | 539.0000 | 2,078,000,000 | 9999.99% | 0.00% |